Wilson Sonsini Goodrich & Rosati and O’Melveny advised Belite Bio on the deal.Belite Bio, Inc., a clinical-stage biopharmaceutical drug development company, announced the pricing of its…
Standard 1 Year Membership Required
You must be a Standard 1 Year member to access this content.
Already a member? Log in here
